Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 2:12 PM View:  | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 26-Feb-24 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.48M to 56.53M | |
| 19-Dec-23 6:08 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 19-Dec-23 | Gift | 210,000 | -- | -- | (< 1%) 56.01M to 55.8M | |
| 27-Nov-23 4:45 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 23-Nov-23 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.63M to 56.69M | |
| 08-Nov-23 3:29 PM View: | Montalbano John S. Director | Abcellera Biologics Inc. (ABCL) | 08-Nov-23 | Purchase | 10,000 | $4.46 | $44,600.00 | 12% 81.0K to 91.0K | |
| 08-Nov-23 3:29 PM View: | Montalbano John S. Director | Abcellera Biologics Inc. (ABCL) | 06-Nov-23 | Private Purchase | 20,000 | $4.64 | $92,800.00 | 33% 61.0K to 81.0K | |
| 26-Sep-23 12:26 PM View: | Hayden Michael R Director | Abcellera Biologics Inc. (ABCL) | 22-Sep-23 | Private Purchase | 20,000 | $4.91 | $98,200.00 | 1% 1.42M to 1.44M | |
| 14-Sep-23 4:38 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 12-Sep-23 | Private Purchase | 20,000 | $5.19 | $103,800.00 | < 1% 9.51M to 9.53M | |
| 25-Aug-23 1:57 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 24-Aug-23 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.57M to 56.63M | |
| 09-Aug-23 12:22 PM View: | Hayden Michael R Director | Abcellera Biologics Inc. (ABCL) | 08-Aug-23 | Private Purchase | 30,000 | $5.90 | $177,000.00 | 2% 1.39M to 1.42M | |
| 26-May-23 2:53 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 26-May-23 | Private Purchase | 14,500 | $6.85 | $99,325.00 | 5% 269.46K to 283.96K | |
| 26-May-23 2:50 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 26-May-23 | Private Purchase | 153,000 | $6.52 | $997,728.00 | < 1% 55.86M to 56.01M | |
| 30-May-23 1:14 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 26-May-23 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.52M to 56.57M | |
| 09-May-23 3:02 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 05-May-23 | Option Exercise | 250,000 | $0.19 | $47,500.00 | 3% 9.26M to 9.51M | |
| 23-Feb-23 4:33 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 22-Feb-23 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.31M to 56.36M | |
| 22-Dec-22 2:31 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 20-Dec-22 | Gift | 50,000 | -- | -- | (16%) 319.46K to 269.46K | |
| 22-Dec-22 2:31 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 20-Dec-22 | Option Exercise | 50,000 | $0.19 | $9,500.00 | 19% 269.46K to 319.46K | |
| 20-Dec-22 10:18 AM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 16-Dec-22 | Private Purchase | 85,102 | $10.10 | $859,249.00 | < 1% 55.77M to 55.86M | |
| 21-Nov-22 9:36 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 18-Nov-22 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 56.17M to 56.22M | |
| 09-Nov-22 7:31 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 31-Oct-22 | Gift | 70,000 | -- | -- | (< 1%) 55.84M to 55.77M | |
| 22-Aug-22 3:27 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 19-Aug-22 | Market Purchase | 200,000 | $11.46 | $2,292,460.00 | < 1% 55.64M to 55.84M | 4% |
| 22-Aug-22 3:09 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 18-Aug-22 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 55.98M to 56.04M | |
| 15-Jun-22 1:14 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 14-Jun-22 | Purchase | 9,173 | $8.05 | $73,841.70 | < 1% 55.64M to 55.64M | |
| 15-Jun-22 1:14 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 13-Jun-22 | Private Purchase | 54,915 | $8.03 | $441,066.00 | < 1% 55.58M to 55.64M | |
| 08-Jun-22 3:32 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 06-Jun-22 | Private Purchase | 64,545 | $7.50 | $483,965.00 | < 1% 55.52M to 55.58M | |
| 19-May-22 1:17 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 18-May-22 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 55.8M to 55.85M | |
| 17-May-22 3:07 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 16-May-22 | Private Purchase | 200,000 | $6.34 | $1,267,780.00 | 2% 9.06M to 9.26M | |
| 17-May-22 3:04 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 13-May-22 | Private Purchase | 300,000 | $7.26 | $2,176,530.00 | < 1% 55.22M to 55.52M | |
| 16-May-22 2:13 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 12-May-22 | Private Purchase | 85,000 | $5.79 | $492,150.00 | 46% 184.46K to 269.46K | |
| 16-May-22 2:14 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 12-May-22 | Private Purchase | 1,408,470 | $6.41 | $9,021,800.00 | 3% 53.81M to 55.22M | |
| 04-Mar-22 4:51 PM View: | Montalbano John S. Director | Abcellera Biologics Inc. (ABCL) | 04-Mar-22 | Private Purchase | 10,000 | $8.54 | $85,400.00 | 20% 51.0K to 61.0K | |
| 03-Mar-22 12:06 PM View: | Montalbano John S. Director | Abcellera Biologics Inc. (ABCL) | 01-Mar-22 | Private Purchase | 20,000 | $9.05 | $181,000.00 | 65% 31.0K to 51.0K | |
| 01-Mar-22 10:00 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 28-Feb-22 | Private Purchase | 230,789 | $8.66 | $1,998,630.00 | 3% 8.83M to 9.06M | |
| 25-Feb-22 1:50 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 22-Feb-22 | Option Exercise | 56,125 | $2.70 | $151,538.00 | < 1% 54.03M to 54.09M | |
| 03-Feb-22 10:00 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 10-Dec-21 | Gift | 500,000 | -- | -- | (73%) 684.46K to 184.46K | |
| 10-Dec-21 5:00 PM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 10-Dec-21 | Option Exercise | 500,000 | $0.32 | $160,000.00 | 271% 184.46K to 684.46K | |
| 03-Feb-22 10:00 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 08-Dec-21 | Gift | 250,000 | -- | -- | (3%) 9.08M to 8.83M | |
| 09-Dec-21 5:49 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 08-Dec-21 | Option Exercise | 250,000 | $0.19 | $47,500.00 | 3% 8.83M to 9.08M | |
| 03-Feb-22 10:00 PM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 07-Dec-21 | Gift | 750,000 | -- | -- | (1%) 54.56M to 53.81M | |
| 03-Feb-22 10:00 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 07-Dec-21 | Gift Duplicate | 750,000 | -- | -- | (1%) 54.78M to 54.03M | |
| 07-Dec-21 3:17 PM View: | Lo Andrew Director | Abcellera Biologics Inc. (ABCL) | 03-Dec-21 | Market Purchase | 86,938 | $14.02 | $1,218,870.00 | 100% 0 to 86.94K | (4%) |
| 03-Feb-22 10:00 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 30-Nov-21 | Gift | 83,333 | -- | -- | (< 1%) 8.91M to 8.83M | |
| 02-Dec-21 2:16 PM View: | Lecault Veronique Chief Operating Officer Director | Abcellera Biologics Inc. (ABCL) | 30-Nov-21 | Option Exercise | 83,333 | $14.96 | $1,246,660.00 | < 1% 8.83M to 8.91M | (3%) |
| 22-Nov-21 5:03 PM View: | Hansen Carl L. G. Chief Executive Officer Director 10% Owner | Abcellera Biologics Inc. (ABCL) | 18-Nov-21 | Option Exercise | 224,500 | $15.03 | $3,374,240.00 | < 1% 56.04M to 56.27M | 5% |
| 15-Nov-21 6:05 AM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 11-Nov-21 | Market Purchase | 53,500 | $14.74 | $788,590.00 | 46% 116.96K to 170.46K | 2% |
| 15-Nov-21 6:05 AM View: | Booth Andrew Chief Financial Officer | Abcellera Biologics Inc. (ABCL) | 11-Nov-21 | Market Purchase | 14,000 | $14.61 | $204,540.00 | 8% 170.46K to 184.46K | 3% |
| 15-Nov-21 6:05 AM View: | Thermopylae Holdings Ltd. 10% Owner | Abcellera Biologics Inc. (ABCL) | 11-Nov-21 | Market Purchase | 202,960 | $14.76 | $2,995,910.00 | < 1% 55.6M to 55.81M | 2% |
| 15-Sep-21 4:12 PM View: | Hayden Michael R Director | Abcellera Biologics Inc. (ABCL) | 13-Sep-21 | Option Exercise | 270,000 | $17.73 | $4,787,100.00 | 24% 1.12M to 1.39M | (< 1%) |
| 02-Sep-21 6:12 PM View: | Hamer John Director | Abcellera Biologics Inc. (ABCL) | 01-Sep-21 | Market Sale | 137,351 | $16.93 | $2,325,350.00 | (< 1%) 14.87M to 14.73M | 0% |
| 02-Sep-21 6:12 PM View: | Hamer John Director | Abcellera Biologics Inc. (ABCL) | 31-Aug-21 | Market Sale | 162,649 | $16.95 | $2,756,900.00 | (1%) 15.03M to 14.87M | < 1% |
| 17-Aug-21 5:47 PM View: | Montalbano John S. Director | Abcellera Biologics Inc. (ABCL) | 16-Aug-21 | Market Purchase | 6,000 | $17.23 | $103,380.00 | 24% 25.0K to 31.0K | 2% |
